| Literature DB >> 26850485 |
Mary B Daly1, Robert Pilarski2, Jennifer E Axilbund3, Michael Berry4, Saundra S Buys5, Beth Crawford6, Meagan Farmer7, Susan Friedman8, Judy E Garber9, Seema Khan10, Catherine Klein11, Wendy Kohlmann5, Allison Kurian12, Jennifer K Litton13, Lisa Madlensky14, P Kelly Marcom15, Sofia D Merajver16, Kenneth Offit17, Tuya Pal18, Huma Rana9, Gwen Reiser19, Mark E Robson17, Kristen Mahoney Shannon20, Elizabeth Swisher21, Nicoleta C Voian22, Jeffrey N Weitzel23, Alison Whelan24, Myra J Wick25, Georgia L Wiesner26, Mary Dwyer27, Rashmi Kumar27, Susan Darlow27.
Abstract
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast and Ovarian provide recommendations for genetic testing and counseling and risk assessment and management for hereditary cancer syndromes. Guidelines focus on syndromes associated with an increased risk of breast and/or ovarian cancer and are intended to assist with clinical and shared decision-making. These NCCN Guidelines Insights summarize major discussion points of the 2015 NCCN Genetic/Familial High-Risk Assessment: Breast and Ovarian panel meeting. Major discussion topics this year included multigene testing, risk management recommendations for less common genetic mutations, and salpingectomy for ovarian cancer risk reduction. The panel also discussed revisions to genetic testing criteria that take into account ovarian cancer histology and personal history of pancreatic cancer.Entities:
Mesh：
Year: 2016 PMID： 26850485 DOI： 10.6004/jnccn.2016.0018
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908